Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.

INTRODUCTION: Severe COVID-19 cases have a detrimental hyper-inflammatory host response and different cytokine-blocking biologic agents were explored to improve outcomes. Anakinra blocks the activity of both IL-1α and IL‑1β and is approved for different autoinflammatory disorders, but it is used off...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Intern Med
Main Authors: Pasin, Laura, Cavalli, Giulio, Navalesi, Paolo, Sella, Nicolò, Landoni, Giovanni, Yavorovskiy, Andrey G., Likhvantsev, Valery V., Zangrillo, Alberto, Dagna, Lorenzo, Monti, Giacomo
Formato: Artigo
Idioma:Inglês
Publicado em: European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7862887/
https://ncbi.nlm.nih.gov/pubmed/33581979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejim.2021.01.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados